全文获取类型
收费全文 | 4618篇 |
免费 | 194篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 61篇 |
妇产科学 | 25篇 |
基础医学 | 543篇 |
口腔科学 | 80篇 |
临床医学 | 250篇 |
内科学 | 1186篇 |
皮肤病学 | 61篇 |
神经病学 | 260篇 |
特种医学 | 203篇 |
外科学 | 946篇 |
综合类 | 21篇 |
预防医学 | 159篇 |
眼科学 | 125篇 |
药学 | 219篇 |
中国医学 | 9篇 |
肿瘤学 | 640篇 |
出版年
2023年 | 27篇 |
2022年 | 65篇 |
2021年 | 159篇 |
2020年 | 62篇 |
2019年 | 79篇 |
2018年 | 102篇 |
2017年 | 75篇 |
2016年 | 117篇 |
2015年 | 112篇 |
2014年 | 160篇 |
2013年 | 212篇 |
2012年 | 315篇 |
2011年 | 328篇 |
2010年 | 191篇 |
2009年 | 163篇 |
2008年 | 273篇 |
2007年 | 328篇 |
2006年 | 275篇 |
2005年 | 277篇 |
2004年 | 308篇 |
2003年 | 301篇 |
2002年 | 286篇 |
2001年 | 47篇 |
2000年 | 39篇 |
1999年 | 43篇 |
1998年 | 71篇 |
1997年 | 67篇 |
1996年 | 50篇 |
1995年 | 39篇 |
1994年 | 34篇 |
1993年 | 29篇 |
1992年 | 25篇 |
1991年 | 21篇 |
1990年 | 14篇 |
1989年 | 13篇 |
1988年 | 11篇 |
1987年 | 20篇 |
1986年 | 8篇 |
1985年 | 17篇 |
1984年 | 10篇 |
1983年 | 4篇 |
1982年 | 12篇 |
1981年 | 9篇 |
1980年 | 7篇 |
1979年 | 6篇 |
1978年 | 2篇 |
1977年 | 7篇 |
1976年 | 5篇 |
1975年 | 2篇 |
1964年 | 2篇 |
排序方式: 共有4833条查询结果,搜索用时 484 毫秒
51.
Rushika M Perera Yoshitaka Narita Frank B Furnari Hui K Gan Carmel Murone Marika Ahlkvist Rodney B Luwor Antony W Burgess Elisabeth Stockert Achim A Jungbluth Lloyd J Old Webster K Cavenee Andrew M Scott Terrance G Johns 《Clinical cancer research》2005,11(17):6390-6399
Monoclonal antibody (mAb) 806 is a novel epidermal growth factor receptor (EGFR) antibody with significant antitumor activity that recognizes a mutant EGFR commonly expressed in glioma known as delta2-7 EGFR (de2-7 EGFR or EGFRvIII) and a subset of the wild-type (wt) EGFR found in cells that overexpress the receptor. We have used two human xenograft mouse models to examine the efficacy of mAb 806 in combination with mAb 528, a prototypical anti-EGFR antibody with similar specificity to cetuximab. Treatment of nude mice, bearing s.c. or i.c. tumor human xenografts expressing the wt or de2-7 EGFR, with mAbs 806 and 528 in combination resulted in additive and in some cases synergistic, antitumor activity. Interestingly, mAb 528 was also effective against xenografts expressing the ligand independent de2-7 EGFR when used as a single agent, showing that its antitumor activity is not merely mediated through inhibition of ligand binding. When used as single agents, neither mAbs 806 or 528 induced down-regulation of the de2-7 EGFR either in vitro or in vivo. In contrast, the combination of antibodies produced a rapid and dramatic decrease in the total cell surface de2-7 EGFR both in vitro and in xenografts. Consistent with this decrease in total cell surface de2-7 EGFR, we observed up-regulation of the cell cycle inhibitor p27(KIP1) and a decrease in tumor cell proliferation as measured by Ki-67 immunostaining when the antibodies were used in combination in vivo. Thus, mAb 806 can synergize with other EGFR-specific antibodies thereby providing a rationale for its translation into the clinic. 相似文献
52.
We investigated the correlation between clinical severity and striatal [123I]-CIT binding in 12 patients with Parkinson's Disease (PD: 6 men and 6 women, age: 65 +/- 7 years, Hoehn & Yahr stage: 1 to 3). The clinical severity of PD patients was measured with the Unified Parkinson's Disease Rating Scale (UPDRS) after withdrawal of antiparkinsonian medication at least 12 hours before assessment. [123I]beta-CIT binding in the caudate and putamen was measured at 3 hours [V'3 (day 1)], and at 24 hours [V'3 (day 2)) after tracer injection with small square ROIs. The specific striatal uptake index (day 2) was calculated with large square ROIs that encompassed the whole striatum. The best correlation (r = -0.82, p < 0.0012) was between putamenal V'3 (day 2) and the motor UPDRS scores. When the motor UPDRS scores were divided into four subscales, bradykinesia was the only sign that correlated significantly with putamenal V'3 (day 2) (r = -0.81, p < 0.002). [123I]beta-CIT SPECT is a useful marker of disease severity in PD with potential utility in the serial monitoring of disease progression. 相似文献
53.
Yoshitaka Maeda Sayaka Yoshida Toshiyuki Hirai Tomoki Kawasaki Tamaki Kuyama 《Journal of Rural Medicine》2013,8(1):171-175
Objective: The usefulness of estimated glomerular filtration rate may not be
restricted to pre-dialysis patients, since we reported that estimated glomerular
filtration rate was well correlated with measured total creatinine clearance in peritoneal
dialysis patients. To clarify the clinical usefulness of estimated glomerular filtration
rate as a parameter for peritoneal dialysis adequacy, we retrospectively surveyed
estimated glomerular filtration rate and total creatinine clearance in peritoneal dialysis
patients treated at JA Toride Medical Center.Patients and Methods: A total of 114 data sets of estimated glomerular
filtration rate and total creatinine clearance from 21 PD patients treated at JA Toride
Medical Center were collected from November 2010 to October 2011. The patients consisted
of 15 men and six women with an average age of 66.6 ± 12.6 years (46–95 years old). The
average number of samples was 5.4 ± 1.5 (2 to 7) per patient.Results: The collected data showed less correlation of estimated glomerular
filtration rate and total creatinine clearance (r. = 0.435) than that of a previous
cross-sectional study (r. = 0.836). As reported in pre-dialysis patients, the differences
between estimated glomerular filtration rate and total creatinine clearance were
correlated with total creatinine excretion in urine and PD effluent (r. = 0.821). The
differences were also correlated with normalized protein catabolic rate, which was one of
the main determinant factors for total creatinine excretion (r. = 0.636). A similar
tendency was apparently observed in one patient with poor compliance to diet therapy and
fluctuating dietary intake. From the analysis of these data, serum creatinine seemed to
fluctuate less possibly due to compensatory capacity of the residual renal function in
small solute clearance.Conclusions: Consequently, estimated glomerular filtration rate was turned
out to be a more stable parameter than total creatinine clearance, which might be a
desirable feature in long-term follow-up of peritoneal dialysis patients. 相似文献
54.
55.
56.
57.
58.
Junya Sakamoto Yoshitaka Manabe Joichi Oyamada Hideki Kataoka Jiro Nakano Kazunobu Saiki Keishi Okamoto Toshiyuki Tsurumoto Minoru Okita 《Clinical anatomy (New York, N.Y.)》2018,31(5):705-709
Introduction : Referred pain in the anterior knee joint is the most common symptom in hip disease patients. The development of referred pain is considered to be related to dichotomizing peripheral sensory fibers. However, no gross anatomical findings identify any dichotomizing fibers innervating both the hip and knee joints. We dissected the femoral and obturator nerves in human cadavers to investigate the distribution of the articular branches in the hip and knee joints. Fourteen embalmed left lower limbs from 14 Japanese adult cadavers (five from females, nine from males, average age 73.8 ± 14.1 years) were observed macroscopically. The articular branches of the femoral and obturator nerves were dissected at the anterior margin of the groin toward the thigh region. After dissections of the articular nerves of the hip joints, the femoral and obturator nerves were exposed from proximally to distally to identify the articular nerves of the knee joints. The branching pattern of the articular branches in the hip and knee joints was recorded. In six of 14 limbs (42.9%), the femoral nerve supplied articular branches to the anteromedial aspect of both the hip and knee joints. These articular branches were derived from the same bundle of femoral nerve. These gross anatomical findings suggested that dichotomizing peripheral sensory fibers innervate the hip and knee joints and these could relate to the referred pain confirmed in the anterior knee joints of patients with hip disease. Clin. Anat. 31:705–709, 2018. © 2018 Wiley Periodicals, Inc. 相似文献
59.
60.
The EBV is a human γ‐herpesvirus associated with various neoplasms. It is responsible for causing cancers of B, T, and NK cells as well as cells of epithelial origin. Such diversity in target cells and the complicated steps of oncogenesis are perplexing when we speculate about the mechanisms of action of EBV‐positive cancers. Here, we first note three common features that contribute to the development and maintenance of EBV‐positive cancers: effects of EBV oncogenes, immunosuppression and evasion/exploitation of the immune system, and genetic and epigenetic predisposition/alteration of the host genome. Then, we demonstrate the mechanisms of oncogenesis and the means by which each EBV‐positive cancer develops, with particular focus on the mode of EBV infection. The EBV has two alternative life cycles: lytic and latent. The latter is categorized into four programs (latency types 0–III) in which latent viral genes are expressed differentially depending on the tissue of origin and state of cells. The production of viral latent genes tends to decrease with an increase in time, and, in an approximate manner, the expression levels of viral genes are inversely correlated with the degree of abnormalities in the host genome. Occasional execution of the viral lytic cycle also contributes to oncogenesis. Understanding this life cycle of the EBV and its relevance in oncogenesis may provide valuable clues to the development of effective therapies for the associated cancers. Copyright © 2014 John Wiley & Sons, Ltd. 相似文献